Concepedia

Publication | Open Access

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

86

Citations

24

References

2021

Year

Abstract

MX2 is a potent indicator for sunitinib resistance and a therapeutic target in ccRCC patients.

References

YearCitations

Page 1